Featured Research

from universities, journals, and other organizations

Risk of suicide, suicide attempt similar across types of antidepressant medication, study finds

Date:
May 4, 2010
Source:
JAMA and Archives Journals
Summary:
Among adults beginning antidepressant therapy, the risk of suicide or suicide attempts does not appear to vary by individual type or class of medication, according to a new study.

Among adults beginning antidepressant therapy, the risk of suicide or suicide attempts does not appear to vary by individual type or class of medication, according to a report in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

"Despite the widespread use of antidepressant medications, particularly selective serotonin reuptake inhibitors (SSRIs), there is inconsistent evidence that growth in antidepressant use has reduced the prevalence of suicidal ideation or suicide attempts during the past decade," the authors write as background information in the article. In October 2004, the U.S. Food and Drug Administration issued an advisory regarding a potentially increased risk in suicidal thoughts and behaviors among children and adolescents taking antidepressants. Subsequent analyses found no increased risk of suicidality in adult antidepressant users; however, these analyses and advisories have not provided patients, clinicians or policy makers with adequate guidance on treatment decisions.

"In the current study, we sought to address whether the risk of suicide is equal across antidepressant classes and agents after adjustment for selection factors -- or whether there are particular regimens with safety advantages that should be prescribed preferentially in adult populations," write Sebastian Schneeweiss, M.D., Sc.D., of Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues. The researchers analyzed health care utilization data from 287,543 adults in British Columbia, Canada, who had initiated antidepressant therapy between 1997 and 2005.

During the first year of antidepressant use, a total of 846 adults in this population either attempted (751) or completed (104) suicide. Most of these events occurred in the first six months after beginning treatment.

There was no clinically meaningful difference in risk among individuals taking different classes of medications, including SSRIs, serotonin-norepinephrine reuptake inhibitors, tricyclic agents and other newer and atypical agents. In addition, there were no significant differences among individual medications, including fluoxetine, citalopram, fluvoxamine, paroxetine and sertraline.

"Our finding of equal event rates across antidepressant agents supports the U.S. Food and Drug Administration's decision to treat all antidepressants alike in their advisory," they conclude. "Treatment decisions should be based on efficacy, and clinicians should be vigilant in monitoring after initiating therapy with any antidepressant agent."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Sebastian Schneeweiss; Amanda R. Patrick; Daniel H. Solomon; Jyotsna Mehta; Colin Dormuth; Matthew Miller; Jennifer C. Lee; Philip S. Wang. Variation in the Risk of Suicide Attempts and Completed Suicides by Antidepressant Agent in Adults: A Propensity Score-Adjusted Analysis of 9 Years' Data. Archives of General Psychiatry, 2010; 67 (5): 497-506 [link]

Cite This Page:

JAMA and Archives Journals. "Risk of suicide, suicide attempt similar across types of antidepressant medication, study finds." ScienceDaily. ScienceDaily, 4 May 2010. <www.sciencedaily.com/releases/2010/05/100503161336.htm>.
JAMA and Archives Journals. (2010, May 4). Risk of suicide, suicide attempt similar across types of antidepressant medication, study finds. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2010/05/100503161336.htm
JAMA and Archives Journals. "Risk of suicide, suicide attempt similar across types of antidepressant medication, study finds." ScienceDaily. www.sciencedaily.com/releases/2010/05/100503161336.htm (accessed July 29, 2014).

Share This




More Mind & Brain News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Losing Sleep Leaves You Vulnerable To 'False Memories'

Losing Sleep Leaves You Vulnerable To 'False Memories'

Newsy (July 27, 2014) A new study shows sleep deprivation can make it harder for people to remember specific details of an event. Video provided by Newsy
Powered by NewsLook.com
University Quiz Implies Atheists Are Smarter Than Christians

University Quiz Implies Atheists Are Smarter Than Christians

Newsy (July 25, 2014) An online quiz from a required course at Ohio State is making waves for suggesting atheists are inherently smarter than Christians. Video provided by Newsy
Powered by NewsLook.com
Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins